CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback